Macrophage activation syndrome

Indian Journal of Rheumatology

Volumn 7, Issue 1 SUPPL., 2012, Pages 27-35

  Lattanzi, Bianca ^a   Davi, Sergio ^a   Rosina, Silvia ^a   Solari, Nicoletta ^a,b   Lanni, Stefano ^b   Bracciolini, Giulia ^a   Martini, Alberto ^a,b   Ravelli, Angelo ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Haemophagocytic lymphohistiocytosis; haemophagocytic syndrome; macrophage activation syndrome; systemic juvenile idiopathic arthritis

Indexed keywords

CYCLOSPORIN A; ETANERCEPT; ETOPOSIDE; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 10; INTERLEUKIN 1BETA; MUNC18 PROTEIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SYNTAXIN; TOCILIZUMAB; TOLL LIKE RECEPTOR 9;

CLINICAL FEATURE; CYTOKINE PRODUCTION; GENE MUTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE ACTIVATION SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 84992261194     PISSN: 09733698     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0973-3698(12)60026-0     Document Type: Review

References (72)

1. AM Prieur, JL Stéphan Macrophage activation syndrome in children with joint diseases Rev Rheum Engl Ed 61 1994 385 388 (Pubitemid 24220712)
2. AA Grom, M Passo Macrophage activation syndrome in systemic juvenile rheumatoid arthritis J Pediatr 129 1996 630 632 (Pubitemid 27498267)
3. S Sawhney, P Woo, KJ Murray Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders Arch Dis Child 85 2001 421 426 (Pubitemid 33702300)
4. JL Stéphan, I Koné-Paut, C Galanbrun, R Mouy, B Bader-Meunier, AM Prieur Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients Rheumatology 40 2001 1285 1292
5. A Ravelli, A Martini Macrophage activation syndrome TH Lehman R Cimaz Pediatric Rheumatology 2008 Elsevier Amsterdam 55 63
6. A Parodi, S Davi, AB Pringe, A Pistorio, N Ruperto, S Magni-Manzoni et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients Arthritis Rheum 60 2009 3388 3399
7. T Avcin, SM Tse, R Schneider, B Ngan, ED Silverman Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood J Pediatr 148 2006 683 686 (Pubitemid 43776910)
8. S Kumar, B Vaidyanathan, S Gayathri, L Rajam Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review Rheumatol Int 2010 [Epub ahead of print.]
9. G Simonini, I Pagnini, L Innocenti, GB Calabri, M De Martino, R Cimaz Macrophage activation syndrome/hemophagocytic lymphohistiocytosis and Kawasaki disease Pediatr Blood Cancer 55 2010 592
10. D Rigante, E Capoluongo, B Bertoni, V Ansuini, A Chiaretti, M Piastra et al. First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome Arthritis Rheum 56 2007 658 661
11. L Rossi-Semerano, B Hermeziu, M Fabre, I Kone-Paut Macrophage activation syndrome revealing familial Mediterranean fever Arthr Care Res 63 2011 780 783
12. A Ravelli Macrophage activation syndrome Curr Opin Rheumatol 14 2002 548 552 (Pubitemid 34953793)
13. B Ramachandran, S Balasubramanian, N Abhishek, KG Ravikumar, AV Ramanan Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India Indian Pediatr 48 2011 31 35
14. L Pinto, F Kagalwala, S Singh, C Balakrishnan, SV Prabhu, S Khodaiji Macrophage activation syndrome: experience from a tertiary referral centre J Assoc Physic Ind 55 2007 185 187
15. EM Behrens, T Beukelman, M Paessler, RQ Cron Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis J Rheumatol 34 2007 1133 1138 (Pubitemid 46774861)
16. J Bleesing, A Prada, DM Siegel, J Villanueva, J Olson, NT Ilowite et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis Arthritis Rheum 56 2007 965 971 (Pubitemid 46399444)
17. IM De Kleer, DM Brinkman, A Ferster, M Abinun, P Quartier, J Van Der Net et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity Ann Rheum Dis 63 2004 1318 1326 (Pubitemid 39273515)
18. A Sreedharan, S Bowyer, CA Wallace, MJ Robertson, K Schmidt, AE Woolfrey et al. Macrophage activation syndrome and other systemic inflammatory conditions after BMT Bone Marrow Transplant 37 2006 629 634
19. M Hadchouel, AM Prieur, C Griscelli Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drug or infection J Pediatr 106 1985 561 566 (Pubitemid 15080542)
20. JL Stéphan, J Zeller, PH Hubert, C Herbelin, JM Dayer, AM Prieur Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases Clin Exp Rheumatol 11 1993 451 456 (Pubitemid 23287170)
21. BH Athreya Is macrophage activation syndrome a new entity? Clin Experim Rheumatol 20 2002 121 123 (Pubitemid 34413689)
22. AV Ramanan, R Schneider Macrophage activation syndrome - what's in a name! J Rheumatol 30 2003 2513 2516 (Pubitemid 37549321)
23. AH Filipovich Hemophagocytic lymphohistiocytosis (HLH) and related disorders Hematol Am Soc Hematol Educ Prog 2009 127 131
24. BE Favara, AC Feller, M Pauli, ES Jaffe, LM Weiss, M Arico et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society Med Pediatr Oncol 29 1997 157 166
25. JI Henter, A Horne, M Aricó, RM Egeler, AH Filipovich, S Imashuku et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis Pediatr Blood Cancer 48 2007 124 131 (Pubitemid 44958267)
26. P Pelkonen, K Swanljung, MA Siimes Ferritinemia as an indicator of systemic disease activity in children with systemic juvenile rheumatoid arthritis Acta Paediatr Scand 75 1986 64 68 (Pubitemid 16126070)
27. B Lattanzi, S Davì, S Rosina, E Demirkaya, N Ruperto, A Martini et al. Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis [Abstract] Ann Rheum Dis 70 Suppl 3 2011 89
28. A Ravelli, S Magni-Manzoni, A Pistorio, C Besana, T Foti, N Ruperto et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis J Pediatr 146 2005 598 604 (Pubitemid 40616243)
29. S Davì, B Lattanzi, E Demirkaya, S Rosina, G Bracciolini, A Novelli et al. Toward the development of new diagnostic criteria for macrophage activation syndrome in sistemi juvenile idiopathic arthritis Ann Paediatr Rheum 1 2012 1 7
30. S Davi, A Consolaro, D Guseinova, A Pistorio, N Ruperto, A Martini et al. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis J Rheumatol 38 2011 764 768
31. AA Grom, ED Mellins Macrophage activation syndrome: advances towards understanding pathogenesis Curr Opin Rheumatol 22 2010 561 566
32. KE Sullivan, CA Delaat, SD Douglas, AH Filipovich Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives Pediatr Res 44 1998 465 468 (Pubitemid 28447329)
33. SE Stepp, R Dufourcq-Lagelouse, F Le Deist, S Bhawan, S Certain, PA Mathew et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis Science 286 1999 1957 1959 (Pubitemid 129515904)
34. J Feldmann, I Callebaut, G Raposo, S Certain, D Bacq, C Dumont et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3) Cell 115 2003 461 473 (Pubitemid 37456808)
35. U zur Stadt, S Schmidt, B Kasper, K Beutel, AS Diler, JI Henter et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11 Hum Mol Genet 14 2005 827 834 (Pubitemid 40403278)
36. U zur Stadt, J Rohr, W Seifert, F Koch, S Grieve, J Pagel et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11 Am J Hum Genet 85 2009 482 492
37. D Kagi, B Odermatt, TW Mak Homeostatic regulation of CD8+ T cells by perforin Eur J Immunol 29 1999 3262 3272 (Pubitemid 29484217)
38. JE Lykens, CE Terrell, EE Zoller, K Risma, MB Jordan Perforin is a critical physiologic regulator of T-cell activation Blood 118 2011 618 626
39. EM Behrens Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell? Autoimmun Rev 7 2008 305 308
40. MB Jordan, D Hildeman, J Kappler, P Marrack An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder Blood 104 2004 735 743 (Pubitemid 38970567)
41. AD Billiau, T Roskams, R Van Damme-Lombaerts, P Matthys, C Wouters Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNFalpha-producing macrophages Blood 105 2005 1648 1651 (Pubitemid 40223686)
42. AA Grom, J Villanueva, S Lee, EA Goldmuntz, MH Passo, A Filipovich Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome J Pediatr 142 2003 292 296 (Pubitemid 36338013)
43. SJ Vastert, R van Wijk, LE D'Urbano, KM de Vooght, W de Jager, A Ravelli et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis Rheumatology 49 2010 441 449
44. J Villanueva, S Lee, EH Giannini, TB Graham, MH Passo, A Filipovich et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome Arthritis Res Ther 7 2005 R30 R37
45. MM Hazen, AL Woodward, I Hofmann, BA Degar, A Grom, AH Filipovich et al. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis Arthritis Rheum 58 2008 567 570 (Pubitemid 351294892)
46. M Yanagimachi, T Naruto, T Miyamae, T Hara, M Kikuchi, R Hara et al. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis J Rheumatol 38 2011 769 774
47. EM Behrens, SW Canna, K Slade, S Rao, PA Kreiger, M Paessler et al. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice J Clin Invest 121 2011 2264 2267
48. K Mazodier, V Marin, D Novick, C Farnarier, S Robitail, N Schleinitz et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome Blood 106 2005 3483 3489 (Pubitemid 41609184)
49. N Maeno, S Takei, Y Nomura, H Imanaka, M Hokonohara, K Miyata Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease [letter] Arthritis Rheum 46 2002 2539 2541
50. MS Fife, A Gutierrez, EM Ogilvie, CJ Stock, JM Samuel, W Thomson et al. Novel IL10 gene family associations with systemic juvenile idiopathic arthritis Arthritis Res Ther 8 2006 R148
51. JC Moller, D Paul, G Ganser, U Range, M Gahr, R Kelsch et al. IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA) Clin Exp Rheumatol 28 2010 912 918
52. A Ravelli, AA Grom, EM Behrens, RQ Cron Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology, and treatment Genes Immun 2012 Mar 15 10.1038/gene.2012.3 [Epub ahead of print].
53. R Mouy, JL Stephan, P Pillet, E Haddad, P Hubert, AM Prieur Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases J Pediatr 129 1996 750 754 (Pubitemid 27498287)
54. A Ravelli, F De Benedetti, S Viola, A Martini Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine J Pediatr 128 1996 275 278 (Pubitemid 26066866)
55. S Singh, S Chandrakasan, J Ahluwalia, D Suri, A Rawat, N Ahmed et al. Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India Rheumatol Int 2011 [Epub ahead of print.]
56. S Kumar, L Rajam Posterior reversible encephalopathy syndrome (PRES/RPLS) during pulse steroid therapy in macrophage activation syndrome Ind J Pediatr 78 2011 1002 1004
57. S Prahalad, KE Bove, D Dickens, DJ Lovell, AA Grom Etanercept in the treatment of macrophage activation syndrome J Rheumatol 28 2001 120 124
58. AV Ramanan, R Schneider Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis J Rheumatol 30 2003 401 403 (Pubitemid 36152611)
59. PM Miettunen, A Narendran, A Jayanthan, EM Behrens, RQ Cron Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients Rheumatology 50 2011 417 419
60. PA Nigrovic, M Mannion, FH Prince, A Zeft, CE Rabinovich, MA van Rossum et al. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series Arthritis Rheum 63 2011 545 555
61. N Bruck, M Suttorp, M Kabus, G Heubner, M Gahr, F Pessler Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids J Clin Rheumatol 17 2011 23 27
62. A Kelly, AV Ramanan A case of macrophage activation syndrome successfully treated with anakinra Nat Clin Pract Rheumatol 4 2008 615 620
63. JL Record, T Beukelman, RQ Cron Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series J Rheumatol 38 2011 180 181
64. A Lurati, B Teruzzi, A Salmaso, G Demarco, I Pontikaki, M Gattinara et al. Macrophage activation syndrome (MAS) during anti-IL1 therapy (anakinra) in a patient affected by systemic juvenile arthritis (soJIA): a report and review of the literature Pediatr Rheumatol Online J 3 2005 79 85
65. A Zeft, R Hollister, B LaFleur, P Sampath, J Soep, B McNally et al. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience J Clin Rheumatol 15 2009 161 164
66. S Yokota, T Imagawa, M Mori, T Miyamae, Y Aihara, S Takei et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial Lancet 371 2008 998 1006 (Pubitemid 351389534)
67. M Kobayashi, Y Takahashi, H Yamashita, H Kaneko, A Mimori Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome Mod Rheumatol 21 2011 92 96
68. A Coca, KW Bundy, B Marston, J Huggins, RJ Looney Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin Clin Immunol 132 2009 10 18
69. N Mahlaoui, M Ouachee-Chardin, G de Saint Basile, B Neven, C Picard, S Blanche et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients Pediatrics 120 2007 e622 e628
70. EI Alexeeva, SI Valieva, TM Bzarova, EL Semikina, KB Isaeva, AO Lisitsyn et al. Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis Clin Rheumatol 30 2011 1163 1172
71. NJ Balamuth, KE Nichols, M Paessler, DT Teachey Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis J Pediatr Hematol Oncol 29 2007 569 573 (Pubitemid 47356813)
72. G Bosman, SM Langemeijer, KM Hebeda, JM Raemaekers, P Pickkers, WJ van der Velden The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis Neth J Med 67 2009 364 365